Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)

被引：0
|
作者：
Guttman-Yassky, E. [1 ]
Pavel, A. B. [1 ]
Page, K. [2 ]
Diaz, A. [1 ]
Banerjee, A. [2 ]
King, B. [3 ]
Zhang, W. [2 ]
Zhu, L. [2 ]
Banfield, C. [2 ]
Cox, L. A. [2 ]
Vincent, M. [2 ]
Dowty, M. [2 ]
Peeva, E. [2 ]
机构：
[1] Icahn Sch Med, New York, NY USA
[2] Pfizer, Cambridge, MA USA
[3] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
544
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 8 条
  • [1] Safety and efficacy of oral JAK inhibitors PF-06651600 and PF-06700841 in a withdrawal/retreatment study in patients with alopecia areata
    Peeva, E.
    Banerjee, A.
    Guttman-Yassky, E.
    Sinclair, R.
    Cox, L. A.
    Zhu, L.
    Zhu, H.
    Vincent, M.
    King, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 116 - 117
  • [2] Evaluation of pharmacology and clinical response to TYK2/JAK1 kinase inhibitor, PF-06700841, in patients with plaque psoriasis
    Page, Karen M.
    Zhang, Weidong
    Scaramozza, Matthew
    Suprun, Maria
    Suarez-Farinas, Mayte
    Fuentes-Duculan, Judilyn
    James, G. Krueger
    Winkle, Peter J.
    Peeva, Elena
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB130 - AB130
  • [3] Clinical efficacy of the oral JAK3/TEC inhibitor ritlecitinib (PF-06651600) and patients' perception of improvement in alopecia areata: Results from the ALLEGRO Phase 2b/3 trial
    Guttman-Yassky, E.
    Ito, T.
    Jabbari, A.
    Mackay-Wiggan, J.
    Lejeune, A.
    Wolk, R.
    Wajsbrot, D.
    Zwillich, S. H.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 20 - 20
  • [4] Selective oral JAK3 and TYK2/JAK1 kinase inhibitors both demonstrate significant hair-growth compared to placebo and improvement of hair-associated keratins in patients with moderate-to-severe Alopecia Areata
    Guttman-Yassky, E.
    Page, K.
    Pavel, A. B.
    Diaz, A.
    Estrada, Y.
    Banerjee, A.
    Zhang, W.
    Zhu, L.
    Banfield, C.
    Cox, L.
    Vincent, M.
    Peeva, E.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 52 - 53
  • [5] Safety of the oral JAK3/TEC inhibitor ritlecitinib (PF-06651600) in patients with alopecia areata: Results from the ALLEGRO phase 2b/3, randomized, double-blind, placebo-controlled trial
    King, Brett
    Szepietowski, Jacek C.
    Farrant, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB106 - AB106
  • [6] Efficacy of the oral JAK3/TEC inhibitor ritlecitinib (PF-06651600) in patients with alopecia areata over 48 weeks: Results from the ALLEGRO Phase 2b/3 randomized, double-blind, placebocontrolled trial
    Mesinkovska, Natasha
    Shapiro, Jerry
    King, Brett
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB54 - AB54
  • [7] Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-(2s,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-y1)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans
    Thorarensen, Atli
    Dowty, Martin E.
    Banker, Mary Ellen
    Juba, Brian
    Jussif, Jason
    Lin, Tsung
    Vincent, Fabien
    Czerwinski, Robert M.
    Casimiro-Garcia, Agustin
    Unwalla, Ray
    Trujillo, John I.
    Liang, Sidney
    Balbo, Paul
    Che, Ye
    Gilbert, Adam M.
    Brown, Matthew F.
    Hayward, Matthew
    Montgomery, Justin
    Leung, Louis
    Yang, Xin
    Soucy, Sarah
    Hegen, Martin
    Coe, Jotham
    Langille, Jonathan
    Vajdos, Felix
    Chrencik, Jill
    Telliez, Jean-Baptiste
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) : 1971 - 1993
  • [8] Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-(1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
    Fensome, Andrew
    Ambler, Catherine M.
    Arnold, Eric
    Banker, Mary Ellen
    Brown, Matthew F.
    Chrencik, Jill
    Clark, James D.
    Dowty, Martin E.
    Efremov, Ivan V.
    Flick, Andrew
    Gerstenberger, Brian S.
    Gopalsamy, Ariamala
    Hayward, Matthew M.
    Hegen, Martin
    Hollingshead, Brett D.
    Jussif, Jason
    Knafels, John D.
    Limburg, David C.
    Lin, David
    Lin, Tsung H.
    Pierce, Betsy S.
    Saiah, Eddine
    Sharma, Raman
    Symanowicz, Peter T.
    Telliez, Jean-Baptiste
    Trujillo, John I.
    Vajdos, Felix F.
    Vincent, Fabien
    Wan, Zhao-Kui
    Xing, Li
    Yang, Xiaojing
    Yang, Xin
    Zhang, Liying
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8597 - 8612
1